• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在美国和英国,迷幻药物使用与异常视觉体验之间的纵向关联。

Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom.

机构信息

Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Stockholm, Sweden.

Department of Sociology, University of Oxford, Oxford, UK.

出版信息

J Psychopharmacol. 2024 Jan;38(1):110-115. doi: 10.1177/02698811231218931. Epub 2023 Dec 23.

DOI:10.1177/02698811231218931
PMID:38140891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10851627/
Abstract

BACKGROUND

Whereas findings from case reports and cross-sectional studies suggest that naturalistic psychedelic use may be associated with unusual visual experiences that occur after the acute pharmacological effects have subsided, such findings need to be replicated in longitudinal studies to better understand potential cause-and-effect relationships.

AIMS

To investigate longitudinal associations between naturalistic psychedelic use and unusual visual experiences.

METHODS

Using a longitudinal observational research design with samples representative of the US and UK adult populations with regard to sex, age, and ethnicity ( = 9732), we investigated the relationship between psychedelic use during the 2-month study period and changes in past-week unusual visual experiences.

RESULTS

The follow-up survey was completed by 79% of respondents ( = 7667), with 100 respondents reporting psychedelic use during the 2-month study period (1.3% of those who responded at follow-up). In covariate-adjusted regression models, the results showed that, as hypothesized, psychedelic use during the 2-month study period was associated with greater increases in unusual visual experiences. Notably, there was an interaction between lifetime psychedelic use and psychedelic use during the study period on unusual visual experiences such that those who used psychedelics for the first time reported greater increases in unusual visual experiences.

CONCLUSIONS

Psychedelic use may elicit unusual visual experiences that occur after the acute pharmacological effects have subsided, especially among those who have not used psychedelics previously. Future longitudinal studies are warranted to further elucidate these relationships.

摘要

背景

尽管病例报告和横断面研究的结果表明,自然主义致幻剂的使用可能与急性药理作用消退后出现的异常视觉体验有关,但这些发现需要在纵向研究中得到复制,以便更好地理解潜在的因果关系。

目的

调查自然主义致幻剂使用与异常视觉体验之间的纵向关联。

方法

使用具有美国和英国成年人口代表性的纵向观察性研究设计,在性别、年龄和种族方面( = 9732),我们调查了在研究期间的 2 个月内使用致幻剂与过去一周异常视觉体验变化之间的关系。

结果

有 79%的受访者( = 7667)完成了随访调查,有 100 名受访者报告在 2 个月的研究期间使用了致幻剂(占随访时回答者的 1.3%)。在调整协变量的回归模型中,结果表明,正如假设的那样,在 2 个月的研究期间使用致幻剂与异常视觉体验的增加呈正相关。值得注意的是,在一生中使用致幻剂和在研究期间使用致幻剂与异常视觉体验之间存在交互作用,即首次使用致幻剂的人报告异常视觉体验的增加更大。

结论

致幻剂的使用可能会引起急性药理作用消退后出现异常视觉体验,尤其是在以前没有使用过致幻剂的人中。需要进行未来的纵向研究来进一步阐明这些关系。

相似文献

1
Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom.在美国和英国,迷幻药物使用与异常视觉体验之间的纵向关联。
J Psychopharmacol. 2024 Jan;38(1):110-115. doi: 10.1177/02698811231218931. Epub 2023 Dec 23.
2
Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom.美国和英国中长期使用迷幻药物与冥想练习之间的关联。
Psychol Med. 2024 Apr;54(6):1228-1234. doi: 10.1017/S0033291723003082. Epub 2023 Oct 20.
3
Psychedelic use and psychiatric risks.迷幻药的使用与精神风险。
Psychopharmacology (Berl). 2023 Oct 24. doi: 10.1007/s00213-023-06478-5.
4
Psychedelics and mental health: a population study.迷幻剂与心理健康:一项人群研究。
PLoS One. 2013 Aug 19;8(8):e63972. doi: 10.1371/journal.pone.0063972. eCollection 2013.
5
Cessation and reduction in alcohol consumption and misuse after psychedelic use.使用迷幻药物后停止和减少酒精消费和滥用。
J Psychopharmacol. 2019 Sep;33(9):1088-1101. doi: 10.1177/0269881119845793. Epub 2019 May 14.
6
Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness.在有迷幻体验的使用者中,只有过去使用过裸盖菇素才能可靠地预测与自然的关系。
J Psychopharmacol. 2023 Jan;37(1):93-106. doi: 10.1177/02698811221146356. Epub 2023 Jan 5.
7
Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.心理洞察问卷在使用裸盖菇素或 LSD 的人群样本中的发展。
J Psychopharmacol. 2021 Apr;35(4):437-446. doi: 10.1177/0269881120967878. Epub 2021 Jan 9.
8
Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics.使用经典迷幻剂时具有挑战性、困难或痛苦的经历的流行程度和关联。
J Affect Disord. 2023 Apr 1;326:105-110. doi: 10.1016/j.jad.2023.01.073. Epub 2023 Jan 30.
9
Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study.设置和情境预测致幻体验的精神病理学、幸福感和意义:一项相关性研究。
Expert Rev Clin Pharmacol. 2024 Jan-Jun;17(2):165-176. doi: 10.1080/17512433.2023.2295997. Epub 2024 Jan 29.
10
Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.LSD 或裸盖菇素(致幻蘑菇)的非法使用与迷幻体验呈剂量依赖性相关,但 MDMA 或非致幻药物则不然。
J Psychoactive Drugs. 2012 Nov-Dec;44(5):410-7. doi: 10.1080/02791072.2012.736842.

引用本文的文献

1
Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.重新审视致幻剂诱发精神病的证据:综述概述、系统评价及人类研究的荟萃分析
Mol Psychiatry. 2025 Mar;30(3):1223-1255. doi: 10.1038/s41380-024-02800-5. Epub 2024 Nov 27.
2
Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?“神秘体验”对于氯胺酮和经典致幻剂的抗抑郁作用是否至关重要?
Eur Arch Psychiatry Clin Neurosci. 2024 Feb 27. doi: 10.1007/s00406-024-01770-7.

本文引用的文献

1
Psychedelic use and psychiatric risks.迷幻药的使用与精神风险。
Psychopharmacology (Berl). 2023 Oct 24. doi: 10.1007/s00213-023-06478-5.
2
Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.评估百忧解辅助治疗抑郁症中症状恶化的风险:系统评价和个体参与者数据荟萃分析。
Psychiatry Res. 2023 Sep;327:115349. doi: 10.1016/j.psychres.2023.115349. Epub 2023 Jul 23.
3
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.裸盖菇素辅助心理治疗与安慰剂治疗酒精使用障碍成年患者后重度饮酒日的百分比:一项随机临床试验。
JAMA Psychiatry. 2022 Oct 1;79(10):953-962. doi: 10.1001/jamapsychiatry.2022.2096.
4
Adolescent and adult time trends in US hallucinogen use, 2002-19: any use, and use of ecstasy, LSD and PCP.美国青少年和成年人在迷幻剂使用方面的时间趋势,2002-2019:任何使用,以及摇头丸、LSD 和 PCP 的使用。
Addiction. 2022 Dec;117(12):3099-3109. doi: 10.1111/add.15987. Epub 2022 Aug 17.
5
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.迷幻剂的不良反应:从传闻和错误信息到系统科学。
J Psychopharmacol. 2022 Mar;36(3):258-272. doi: 10.1177/02698811211069100. Epub 2022 Feb 2.
6
Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.在有健康参与者参与的对照研究中,使用 LSD 和裸盖菇素后出现闪回现象。
Psychopharmacology (Berl). 2022 Jun;239(6):1933-1943. doi: 10.1007/s00213-022-06066-z. Epub 2022 Jan 25.
7
Safety pharmacology of acute LSD administration in healthy subjects.健康受试者中 LSD 急性给药的安全性药理学。
Psychopharmacology (Berl). 2022 Jun;239(6):1893-1905. doi: 10.1007/s00213-021-05978-6. Epub 2021 Sep 13.
8
On Perception and Consciousness in HPPD: A Systematic Review.关于致幻剂持续性知觉障碍(HPPD)中的知觉与意识:一项系统综述
Front Neurosci. 2021 Aug 11;15:675768. doi: 10.3389/fnins.2021.675768. eCollection 2021.
9
The Current Status of Psychedelics in Psychiatry.精神药物在精神病学中的现状
JAMA Psychiatry. 2021 Feb 1;78(2):121-122. doi: 10.1001/jamapsychiatry.2020.2171.
10
Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings.在自然环境中,转变体验和社会联系会调节迷幻类药物使用对情绪的增强作用。
Proc Natl Acad Sci U S A. 2020 Feb 4;117(5):2338-2346. doi: 10.1073/pnas.1918477117. Epub 2020 Jan 21.